# Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection

> **NCT05586815** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 94 (estimated)

## Conditions studied

- Acinetobacter Infections

## Interventions

- **DRUG:** Colistin
- **DRUG:** Minocycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05586815
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-10
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2023-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586815, "Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT05586815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*